Recently, KIF11 has been reported to be a novel potential candidate prognostic biomarker or therapeutic target in human cancers including breast cancer [64], ovarian cancer [65], oral cancer [66], peripheral nerve sheath tumors [67, 68], and lung cancer [69]. This evidence concerns the gene KIF11 and cancer.